 |
Top 16 medical and healthcare startups in Oxford
Sep 23, 2025 | By Jason Kwon | 30 |
1
Funding: £1.1B
Oxford Nanopore Technologies has developed the world's first and only nanopore DNA sequencer, the MinION. The MinION is a portable, real time, long-read, low cost device that has been designed to bring easy biological analyses to anyone, whether in scientific research, education or a range of real world applications such as disease/pathogen surveillance, environmental monitoring, food chain surveillance, self-quantification or even microgravity biology.
Oxford Nanopore Technologies has developed the world's first and only nanopore DNA sequencer, the MinION. The MinION is a portable, real time, long-read, low cost device that has been designed to bring easy biological analyses to anyone, whether in scientific research, education or a range of real world applications such as disease/pathogen surveillance, environmental monitoring, food chain surveillance, self-quantification or even microgravity biology.
2
Funding: $474.4M
Exscientia is applying AI and big data processing to accelerate drug discovery and development.
Exscientia is applying AI and big data processing to accelerate drug discovery and development.
3
Funding: $240M
Barinthus Biotherapeutics is creating novel vaccines that elicit strong responses from helper and cytotoxic T-cells.
Barinthus Biotherapeutics is creating novel vaccines that elicit strong responses from helper and cytotoxic T-cells.
4
Funding: $239.7M
PepGen is empowering nucleic acid therapeutics to go the distance and building neuromuscular and neurologic pipeline.
PepGen is empowering nucleic acid therapeutics to go the distance and building neuromuscular and neurologic pipeline.
5
Funding: $189M
OrganOx develops a revolutionary device for storing livers at normal body temperatures for extended periods of time. Following extensive pre-clinical studies and the successful completion of clinical studies, the product is now commercially available within the EU.
OrganOx develops a revolutionary device for storing livers at normal body temperatures for extended periods of time. Following extensive pre-clinical studies and the successful completion of clinical studies, the product is now commercially available within the EU.
6
Funding: £128M
OMass Therapeutics develops new medicines against highly validated but inadequately drugged targets using novel biochemistry techniques, native mass spectrometry and custom chemistry.
OMass Therapeutics develops new medicines against highly validated but inadequately drugged targets using novel biochemistry techniques, native mass spectrometry and custom chemistry.
7
Funding: $130M
MiroBio develops novel, best-in-class therapeutics that bring significant benefits to patients suffering from a range of auto-immune diseases. MiroBio's medicines will activate natural mechanisms to regain control of over-active immune responses triggering these diseases.
MiroBio develops novel, best-in-class therapeutics that bring significant benefits to patients suffering from a range of auto-immune diseases. MiroBio's medicines will activate natural mechanisms to regain control of over-active immune responses triggering these diseases.
8
Funding: $113.8M
Ultromics clinicians and engineers working together to set new standards for world-class cardiovascular diagnostic tools.
Ultromics clinicians and engineers working together to set new standards for world-class cardiovascular diagnostic tools.
9
Funding: $64.3M
Theolytics is a biotechnology company harnessing viruses to combat cancer. A step-change in the oncolytic viral therapy field, our phenotypic screening Platform enables the discovery and development of efficacious, targeted candidates suitable for intravenous delivery and optimised for a chosen patient population.
Theolytics is a biotechnology company harnessing viruses to combat cancer. A step-change in the oncolytic viral therapy field, our phenotypic screening Platform enables the discovery and development of efficacious, targeted candidates suitable for intravenous delivery and optimised for a chosen patient population.
10
Funding: $53.7M
Using Artificial Intelligence (AI), deep learning algorithms Brainomix team is bringing complete stroke imaging decision support solution to hospitals worldwide.
Using Artificial Intelligence (AI), deep learning algorithms Brainomix team is bringing complete stroke imaging decision support solution to hospitals worldwide.
12
Funding: $28.4M
Oxford Endovascular are developing a novel treatment for treating brain aneurysms.
Oxford Endovascular are developing a novel treatment for treating brain aneurysms.
14
Funding: $12.5M
Oxford Vacmedix develops therapeutic agents for the treatment of cancer based on the Recombinant Overlapping Peptides (ROP).
Oxford Vacmedix develops therapeutic agents for the treatment of cancer based on the Recombinant Overlapping Peptides (ROP).
15
Funding: $11.3M
Oxford Drug Design focuses on developing and delivering services and technologies in computer-aided drug discovery.
Oxford Drug Design focuses on developing and delivering services and technologies in computer-aided drug discovery.
16
Funding: $75K
An app inspired by science helping to slow down Parkinson's disease progression and improve quality of life. PD Buddy is the first app of Good Vibes Technologies, focusing on self-care for people with neurodegenerative diseases.
An app inspired by science helping to slow down Parkinson's disease progression and improve quality of life. PD Buddy is the first app of Good Vibes Technologies, focusing on self-care for people with neurodegenerative diseases.
★
See also:
